NWF Advisory Services’s Gilead Sciences GILD Stock Holding History

NWF Advisory Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$232K	Buy	1,837 +3	+0.2%	+$395	0.02%	366
2026 Q1	$256K	Buy	1,834 +1	+0.1%	+$140	0.03%	321
2025 Q4	$225K	Buy	+1,833	New	+$223K	0.02%	338
2025 Q3	–	Sell	-2,162	Closed	-$240K	–	432
2025 Q2	$240K	Buy	2,162 +299	+16%	+$31.8K	0.03%	337
2025 Q1	$209K	Sell	1,863 -372	-17%	-$38.4K	0.03%	318
2024 Q4	$206K	Buy	+2,235	New	+$201K	0.03%	253

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NWF Advisory Services's GILD Position: Q2 2026 in Review

NWF Advisory Services increased its Gilead Sciences (GILD) stake by 0.16% in Q2 2026, buying an estimated $395 and bringing the position to 1,837 shares worth $232K. The position accounts for 0.02% of the portfolio, ranked #366.

NWF Advisory Services first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. The position peaked at $256K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

NWF Advisory Services held 1,837 shares of Gilead Sciences worth $232K as of Q2 2026.
NWF Advisory Services bought 3 Gilead Sciences shares in Q2 2026, an estimated $395.
Gilead Sciences made up 0.02% of NWF Advisory Services's portfolio in Q2 2026, its #366 holding.
NWF Advisory Services first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
NWF Advisory Services's Gilead Sciences position peaked at $256K in Q1 2026.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on NWF Advisory Services's 13F filing for Q2 2026, filed 29 Jul 2026.